After a string of years characterized by growth for Novo Nordisk, in 2022, the Danish pharmaceutical firm has been hit by a large pricing reform in China. More challenges loom on the horizon in the country, which is the firm’s second-biggest market, as reported by Danish media Finans.
This is because the company’s patent protection on some products are slated to terminate in coming years – starting with Tresiba, Ryzodeg, and Xultophy in 2024. Two years later, the patent for Novo Nordisk’s bestselling drug, GLP-1-based Ozempic, will expire in 2026.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
The US Food and Drug Administration will receive a marketing authorization application from Genmab and partner Abbvie in the second half of this year.
Novo Nordisk denied general conditional reimbursement for Wegovy in Denmark – again
The Danish Medicines Agency has been told for the second time that the price of the obesity drug is not in line with the effect it provides.
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Coloplast's climate goals approved by international initiative
The Science Based Targets initiative has approved Coloplast’s carbon emission reduction goals.
Top news from MedWatch this week
Miss anything?
Scientific Writer 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Corporate Quality Compliance Supporter - Digital QMS/IT Validation 
Global Learning Specialist 
QA Specialist for Product Equipment Qualification 
Principal Scientist – Pharmacology 
Senior Scientist for Analytical Development 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Project Managers keep all of us healthy 
Medical Advisor 
Director Regulatory Affairs 
Nordic Medical Advisor